
Currently out of the existing stock ratings of Chris Schott, 227 are a BUY (67.16%), 98 are a HOLD (28.99%), 13 are a SELL (3.85%).
Analyst Chris Schott, currently employed at JPMORGAN, has had 53.46% of price targets met with an average potential upside of 27.61%, reached in 341 days on average.
Chris Schott has documented 657 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 09-Nov-2026.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) on 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%), with a performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$338
$42.97 (14.56%)
$282
14 days ago
(02-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 05-Feb-2020
$322
$26.97 (9.14%)
$288
14 days ago
(02-Nov-2026)
45/46 (97.83%)
$27.11 (9.19%)
407
Buy Since 08-Dec-2021
$340
$44.97 (15.24%)
$300
14 days ago
(02-Nov-2026)
11/13 (84.62%)
$45.11 (15.30%)
479
Buy Since 02-Nov-2026
$342
$46.97 (15.92%)
$206
14 days ago
(02-Nov-2026)
19/20 (95%)
$47.11 (15.98%)
376
Buy Since 25-Feb-2026
$330
$34.97 (11.85%)
$280
14 days ago
(02-Nov-2026)
7/8 (87.5%)
$35.11 (11.91%)
173
Which stock is Chris Schott most bullish on?
Which stock is Chris Schott most reserved on?
What Year was the first public recommendation made by Chris Schott?